Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Multistrada Arah Sarana Tbk. (MASA)

UBC Medical Indonesia Tbk.Trading
Multistrada Arah Sarana Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Multistrada Arah Sarana Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb), sedangkan Multistrada Arah Sarana Tbk. diperdagangkan di Rp6.200 (kapitalisasi pasar 56,93 T). Perbedaan utamanya: Multistrada Arah Sarana Tbk. jauh lebih besar — sekitar 82,4× kapitalisasi pasar UBC Medical Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

LABSMASA
Kapitalisasi Pasar
691,25 M56,93 T
Volume
635,5 rb
Lot
6,36 rb
Perputaran
110,15 jt
Harga Rata-rata
173,33
Nilai Transaksi
110,15 jt
Harga Ekuilibrium Indikatif
174
Volume Ekuilibrium Indikatif
50

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
MASA
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Multistrada Arah Sarana Tbk.

Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.

Selengkapnya di halaman MASA